New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay
Open accessAbstract
Previous studies have developed vascularized tumor spheroid models to demonstrate the impact of intravascular flow on tumor progression and treatment. However, these models have not been widely adopted so the vascularization of tumor spheroids in vitro is generally lower than vascularized tumor tissues in vivo. To improve the tumor vascularization level, a new strategy is introduced to form tumor spheroids by adding fibroblasts (FBs) sequentially to a pre‐formed tumor spheroid and demonstrate this method with tumor cell lines from kidney, lung, and ovary cancer. Tumor spheroids made with the new strategy have higher FB densities on the periphery of the tumor spheroid, which tend to enhance vascularization. The vessels close to the tumor spheroid made with this new strategy are more perfusable than the ones made with other methods. Finally, chimeric antigen receptor (CAR) T cells are perfused under continuous flow into vascularized tumor spheroids to demonstrate immunotherapy evaluation using vascularized tumor‐on‐a‐chip model. This new strategy for establishing tumor spheroids leads to increased vascularization in vitro, allowing for the examination of immune, endothelial, stromal, and tumor cell responses under static or flow conditions.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Several other tumor chips have been developed, encompassing features such as tumor vasculature, stromal cells, or immune cells, and offering advantages in terms of rapid fabrication, reproducibility, real-time imaging and analysis, capturing tumor type and heterogeneity, facilitating robust drug testing, target discovery and personalized therapy screenings, and enabling multicellular crosstalk.
“Besides this model, several other tumor chips have been developed, encompassing features such as tumor vasculature (Yu et al. (2019); Wan et al. (2023); Nashimoto et al. (2020); Neufeld et al. (2021); Kim et al. (2022); Mannino et al. (2017); Shirure et al. (2018), stromal cells (Yu et al. (2019); Ibrahim et al. (2022); Karakas et al. (2017), or immune cells (Surendran et al. (2021); Aung et al. (”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Wan et al., 2023
In ovarian cancer MPS, a microfluidic device with three parallel channels using ECs, fibroblasts, SKOV3, OV90 spheroids, and CAR T cells showed a high level of tumor vascularization and recruitment of CAR T cells.
“| Ovarian | Wan et al. (2023) | Microfluidic device with three parallel channels | ECs, fibroblasts, SKOV3, OV90 spheroids, CAR T cells | High level of tumor vascularization and recruitment of CAR T cells |”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Wan et al., 2023
Wan et al. developed a tumor spheroid model that allows high tumor vascularization via a living vasculature network and elucidation of the role of fibroblasts within the tumor microenvironment.
“In an approach to improve tumor architecture, promote tumor-stromal interactions and promote tumor vascularization, Wan and colleagues developed a tumor spheroid model that allows for high levels of tumor vascularization via a living vasculature network and further allows elucidation of the role of fibroblasts within the TME (Wan et al., 2023).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Wan et al., 2023
The sequential spheroid result is indicative of complex microenvironmental remodeling and enhanced angiogenesis typical of in vivo vascularized tumors.
“Interestingly, the tumor spheroids formed by the sequential approach led to the highest level of tumor vascularization, vessel perfusability and fibroblast area, which is indicative of complex microenvironmental remodeling processes and enhanced angiogenesis that typically occurs in in vivo vascularized tumors (Wan et al., 2023).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Wan et al., 2023
Tumor spheroids formed by sequential addition of fibroblasts to pre-formed tumor spheroids led to the highest level of tumor vascularization, vessel perfusability, and fibroblast area.
“Interestingly, the tumor spheroids formed by the sequential approach led to the highest level of tumor vascularization, vessel perfusability and fibroblast area, which is indicative of complex microenvironmental remodeling processes and enhanced angiogenesis that typically occurs in in vivo vascularized tumors (Wan et al., 2023).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Wan et al., 2023
CAR T cells were recruited to tumor spheroids, extravasated from tumor vessels, interacted with tumor cells, and led to a strong IFN-γ response and higher density of dead cells in the tumor region.
“Interestingly, CAR T cells were recruited to the tumor spheroids, extravasated from the tumor vessels and engaged in interactions with tumor cells; leading to a strong IFN-γ response and a higher density of dead cells in the tumor region (Wan et al., 2023).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Wan et al., 2023
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A framework for advancing our understanding of cancer-associated fibroblasts
Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863 · see citing works
Car t cell immunotherapy for human cancer
June, C. H., O’Connor, R. S., Kawalekar, O. U., Ghassemi, S., & Milone, M. C. (2018) · Science · doi:10.1126/science.aar6711 · Cited by 3,207 · see citing works
CAR-T cell therapy: current limitations and potential strategies
Sterner, R. C., & Sterner, R. M. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00459-7 · Cited by 2,926 · see citing works
Tumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784 · see citing works
The differential adhesion hypothesis: a direct evaluation
Foty, R. A., & Steinberg, M. S. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2004.11.012 · Cited by 908 · see citing works
Engineering of functional, perfusable 3D microvascular networks on a chip
Kim, S., Lee, H., Chung, M., & Jeon, N. L. (2013) · Lab on a Chip · doi:10.1039/c3lc41320a · Cited by 872 · see citing works
Hassell, B. A., Goyal, G., Lee, E., Sontheimer-Phelps, A., Levy, O., Chen, C. S., & Ingber, D. E. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.043 · Cited by 467 · see citing works
3D microtumors in vitro supported by perfused vascular networks
Sobrino, A., Phan, D. T. T., Datta, R., Wang, X., Hachey, S. J., Romero-López, M., Gratton, E., Lee, A. P., George, S. C., & Hughes, C. C. W. (2016) · Scientific Reports · doi:10.1038/srep31589 · Cited by 387 · see citing works
Self-citationVascularized cancer on a chip: the effect of perfusion on growth and drug delivery of tumor spheroid
Nashimoto, Y., Okada, R., Hanada, S., Arima, Y., Nishiyama, K., Miura, T., & Yokokawa, R. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119547 · Cited by 332 · see citing works
Paek, J., Park, S. E., Lu, Q., Park, K.-T., Cho, M., Oh, J. M., Kwon, K. W., Yi, Y.-S., Song, J. W., Edelstein, H. I., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b00686 · Cited by 238 · see citing works
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227 · see citing works
Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery
Agarwal, P., Wang, H., Sun, M., Xu, J., Zhao, S., Liu, Z., Gooch, K. J., Zhao, Y., Lu, X., & He, X. (2017) · ACS Nano · doi:10.1021/acsnano.7b00824 · Cited by 168 · see citing works
Lai, B. F. L., Lu, R. X. Z., Hu, Y., Davenport Huyer, L., Dou, W., Wang, E. Y., Radulovich, N., Tsao, M. S., Sun, Y., & Radisic, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000545 · Cited by 142 · see citing works
Hachey, S. J., Movsesyan, S., Nguyen, Q. H., Burton-Sojo, G., Tankazyan, A., Wu, J., Hoang, T., Zhao, D., Wang, S., Hatch, M. M., et al. (2021) · Lab on a Chip · doi:10.1039/d0lc01216e · Cited by 124 · see citing works
Xiao, Y., Kim, D., Dura, B., Zhang, K., Yan, R., Li, H., Han, E., Ip, J., Zou, P., Liu, J., et al. (2019) · Advanced Science · doi:10.1002/advs.201801531 · Cited by 115 · see citing works
Flagged first, then by citations
Research works printed but not linked: 90
- [1]Z. Liu, Y. Wang, Y. Huang, B. Y. S. Kim, H. Shan, D. Wu, W. Jiang, Trends Pharmacol. Sci. 2019, 40, 613. 31331639 PMC7925217
- [2]R. Baghban, L. Roshangar, R. Jahanban‐Esfahlan, K. Seidi, A. Ebrahimi‐Kalan, M. Jaymand, S. Kolahian, T. Javaheri, P. Zare, Cell Commun. Signaling 2020, 18, 59. PMC7140346 32264958
- [3]A. Sontheimer‐Phelps, B. A. Hassell, D. E. Ingber, Nat. Rev. Cancer 2019, 19, 65. 30647431
- [4]N. D. Piccolo, V. S. Shirure, Y. Bi, S. P. Goedegebuure, S. Gholami, C. C. W. Hughes, R. C. Fields, S. C. George, Adv. Drug Delivery Rev. 2021, 175, 113798. 34015419
- [5]X. Liu, J. Fang, S. Huang, X. Wu, X. Xie, J. Wang, F. Liu, M. Zhang, Z. Peng, N. Hu, Microsyst. Nanoeng. 2021, 7, 50. 34567763 PMC8433302
- [6]M. Shang, R. H. Soon, C. T. Lim, B. L. Khoo, J. Han, Lab Chip 2019, 19, 369. 30644496
- [7]V. S. Shirure, C. C. W. Hughes, S. C. George, Annu. Rev. Biomed. Eng. 2021, 23, 141. 33756087
- [8]Y. Wu, Y. Zhou, X. Qin, Y. Liu, Biomicrofluidics 2021, 15, 061503. 34804315 PMC8589468
- [9]K. Haase, G. S. Offeddu, M. R. Gillrie, R. D. Kamm, Adv. Funct. Mater. 2020, 30, 2002444. 33692661 PMC7939067
- [10]J. Paek, S. E. Park, Q. Lu, K.‐T. Park, M. Cho, J. M. Oh, K. W. Kwon, Y.‐S. Yi, J. W. Song, H. I. Edelstein, J. Ishibashi, W. Yang, J. W. Myerson, R. Y. Kiseleva, P. Aprelev, E. D. Hood, D. Stambolian, P. Seale, V. R. Muzykantov, D. Huh, ACS Nano 2019, 13, 7627. 31194909
- [11]J. P. Straehla, C. Hajal, H. C. Safford, G. S. Offeddu, N. Boehnke, T. G. Dacoba, J. Wyckoff, R. D. Kamm, P. T. Hammond, Proc. Natl. Acad. Sci. U. S. A. 2022, 119, e2118697119. 35648828 PMC9191661
- [12]M. Campisi, S. K. Sundararaman, S. E. Shelton, E. H. Knelson, N. R. Mahadevan, R. Yoshida, T. Tani, E. Ivanova, I. Cañadas, T. Osaki, S. W. L. Lee, T. Thai, S. Han, B. P. Piel, S. Gilhooley, C. P. Paweletz, V. Chiono, R. D. Kamm, S. Kitajima, D. A. Barbie, Front. Immunol. 2020, 11, 2090. 33013881 PMC7507350
- [13]D. Kim, K. S. Hwang, E. U. Seo, S. Seo, B. C. Lee, N. Choi, J. Choi, H. N. Kim, Adv. Healthcare Mater. 2022, 11, 2102581. PMC11468795 35286780
- [14]Y. Bi, V. S. Shirure, R. Liu, C. Cunningham, L. Ding, J. M. Meacham, S. P. Goedegebuure, S. C. George, R. C. Fields, Integr. Biol. 2020, 12, 221. PMC7525664 32930334
- [15]J. M. Ayuso, S. Rehman, M. Virumbrales‐Munoz, P. H. Mcminn, P. Geiger, C. Fitzgerald, T. Heaster, M. C. Skala, D. J. Beebe, Sci. Adv. 2021, 7. PMC7888951 33597234
- [16]J. Lee, S.‐E. Kim, D. Moon, J. Doh, Lab Chip 2021, 21, 2142. 33913456
- [17]Y. Xiao, D. Kim, B. Dura, K. Zhang, R. Yan, H. Li, E. Han, J. Ip, P. Zou, J. Liu, A. T. Chen, A. O. Vortmeyer, J. Zhou, R. Fan, Adv. Sci. 2019, 6, 1801531. PMC6468969 31016107
- [18]R. Michna, M. Gadde, A. Ozkan, M. Dewitt, M. Rylander, Biotechnol. Bioeng. 2018, 115, 2793. 29940072 PMC6261298
- [19]A. Sobrino, D. T. T. Phan, R. Datta, X. Wang, S. J. Hachey, M. Romero‐López, E. Gratton, A. P. Lee, S. C. George, C. C. W. Hughes, Sci. Rep. 2016, 6, 31589. 27549930 PMC4994029
- [20]Y. Wang, R. K. Kankala, J. Zhang, L. Hao, K. Zhu, S. Wang, Y. S. Zhang, A. Chen, Adv. Sci. 2020, 7, 2002002. PMC7610277 33173735
- [21]P. Agarwal, H. Wang, M. Sun, J. Xu, S. Zhao, Z. Liu, K. J. Gooch, Y. Zhao, X. Lu, X. He, ACS Nano 2017, 11, 6691. 28614653 PMC5663446
- [22]M. Dey, B. Ayan, M. Yurieva, D. Unutmaz, I. T. Ozbolat, Adv. Biol. 2021, 5, e2100090. PMC8574137 33857356
- [23]F. L. L. Benjamin, X. Lu Rick, Y. Hu, H. L. Davenport, W. Dou, E. Y. Wang, N. Radulovich, M. S. Tsao, Y. Sun, M. Radisic, Adv. Funct. Mater. 2020, 30, 2000545. 33692660 PMC7939064
- [24]S. Park, T. Kim, S. Kim, S. You, Y. Jung, Cancers 2021, 13, 3930.34439103
- [25]G. Silvani, C. Basirun, H. J. Wu, C. Mehner, K. Poole, P. Bradbury, J. Chou, Adv. Ther. 2021, 4, 2100106.
- [26]B. A. Hassell, G. Goyal, E. Lee, A. Sontheimer‐Phelps, O. Levy, C. S. Chen, D. E. Ingber, Cell Rep. 2017, 21, 508. 29020635
- [27]J. Ko, J. Ahn, S. Kim, Y. Lee, J. Lee, D. Park, N. L. Jeon, Lab Chip 2019, 19, 2822. 31360969
- [28]S. J. Hachey, S. Movsesyan, Q. H. Nguyen, G. Burton‐Sojo, A. Tankazyan, J. Wu, T. Hoang, D. Zhao, S. Wang, M. M. Hatch, E. Celaya, S. Gomez, G. T. Chen, R. T. Davis, K. Nee, N. Pervolarakis, D. A. Lawson, K. Kessenbrock, A. P. Lee, J. Lowengrub, M. L. Waterman, C. C. W. Hughes, Lab Chip 2021, 21, 1333. 33605955 PMC8525497
- [29]Y. Nashimoto, R. Okada, S. Hanada, Y. Arima, K. Nishiyama, T. Miura, R. Yokokawa, Biomaterials 2020, 229, 119547. 31710953
- [30]Z. Hu, Y. Cao, E. A. Galan, L. Hao, H. Zhao, J. Tang, G. Sang, H. Wang, B. Xu, S. Ma, ACS Biomater. Sci. Eng. 2022, 8, 1215. 35167260
- [31]C. H. June, R. S. O'connor, O. U. Kawalekar, S. Ghassemi, M. C. Milone, Science 2018, 359, 1361. 29567707
- [32]C. H. June, M. Sadelain, N. Engl. J. Med. 2018, 379, 64. 29972754 PMC7433347
- [33]A. J. Hou, L. C. Chen, Y. Y. Chen, Nat. Rev. Drug Discovery 2021, 20, 531. 33972771
- [34]M. Martinez, E. K. Moon, Front. Immunol. 2019, 10, 128. 30804938 PMC6370640
- [35]R. C. Sterner, R. M. Sterner, Blood Cancer J. 2021, 11, 69. 33824268 PMC8024391
- [36]M. Boulch, M. Cazaux, Y. Loe‐Mie, R. Thibaut, B. Corre, F. Lemaître, C. L. Grandjean, Z. Garcia, P. Bousso, Sci. Immunol. 2021, 6. 33771887
- [37]A. Rodriguez‐Garcia, A. Palazon, E. Noguera‐Ortega, D. J. Powell, S. Guedan, Front. Immunol. 2020, 11, 1109. 32625204 PMC7311654
- [38]K. Paterson, S. Paterson, T. Mulholland, S. B. Coffelt, M. Zagnoni, IEEE Open J. Eng. Med. Biol. 2022, 3, 86. 35813488 PMC9252335
- [39]F. Jacob, R. D. Salinas, D. Y. Zhang, P. T. T. Nguyen, J. G. Schnoll, S. Z. H. Wong, R. Thokala, S. Sheikh, D. Saxena, S. Prokop, D.‐A. Liu, X. Qian, D. Petrov, T. Lucas, H. I. Chen, J. F. Dorsey, K. M. Christian, Z. A. Binder, M. Nasrallah, S. Brem, D. M. O'rourke, G.‐L. Ming, H. Song, Cell 2020, 180, 188. 31883794 PMC7556703
- [40]J. Michie, P. A. Beavis, A. J. Freeman, S. J. Vervoort, K. M. Ramsbottom, V. Narasimhan, E. J. Lelliott, N. Lalaoui, R. G. Ramsay, R. W. Johnstone, J. Silke, P. K. Darcy, I. Voskoboinik, C. J. Kearney, J. Oliaro, Cancer Immunol. Res. 2019, 7, 183. 30651288
- [41]Y. Ando, E. L. Siegler, H. P. Ta, G. E. Cinay, H. Zhou, K. A. Gorrell, H. Au, B. M. Jarvis, P. Wang, K. Shen, Adv. Healthcare Mater. 2019, 8, e1900001. PMC6448565 30734529
- [42]J. Pan, J. Mestas, M. D. Burdick, R. J. Phillips, G. V. Thomas, K. Reckamp, J. A. Belperio, R. M. Strieter, Mol. Cancer 2006, 5, 56. 17083723 PMC1636662
- [43]D. Huang, Y. Ding, M. Zhou, B. I. Rini, D. Petillo, C.‐N. Qian, R. Kahnoski, P. A. Futreal, K. A. Furge, B. T. Teh, Cancer Res. 2010, 70, 1063. 20103651 PMC3719378
- [44]A. Amann, M. Zwierzina, S. Koeck, G. Gamerith, E. Pechriggl, J. M. Huber, E. Lorenz, J. M. Kelm, W. Hilbe, H. Zwierzina, J. Kern, Sci. Rep. 2017, 7, 2963. 28592821 PMC5462801
- [45]I. Cañadas, F. Rojo, Á. Taus, O. Arpí, M. Arumí‐Uría, L. Pijuan, S. Menéndez, S. Zazo, M. Dómine, M. Salido, S. Mojal, A. G. De Herreros, A. Rovira, J. Albanell, E. Arriola, Clin. Cancer Res. 2014, 20, 938. 24284055
- [46]Y. Zhang, C. K. Elechalawar, W. Yang, A. N. Frickenstein, S. Asfa, K.‐M. Fung, B. N. Murphy, S. K. Dwivedi, G. Rao, A. Dey, Mater. Today 2022, 56, 1369. PMC9523457 36188120
- [47]Z. Zhang, D. Jiang, H. Yang, Z. He, X. Liu, W. Qin, L. Li, C. Wang, Y. Li, H. Li, H. Xu, H. Jin, Q. Qian, Cell Death Dis. 2019, 10, 476. 31209210 PMC6572851
- [48]A. Morello, M. Sadelain, P. S. Adusumilli, Cancer Discov 2016, 6, 133. 26503962 PMC4744527
- [49]M. Shao, S. Hollar, D. Chambliss, J. Schmitt, R. Emerson, B. Chelladurai, S. Perkins, M. Ivan, D. Matei, Mol. Cancer Ther. 2012, 11, 1576. 22700681 PMC4497519
- [50]A. Agarwal, L. Covic, L. M. Sevigny, N. C. Kaneider, K. Lazarides, G. Azabdaftari, S. Sharifi, A. Kuliopulos, Mol. Cancer Ther. 2008, 7, 2746. 18790755 PMC2735132
- [51]G. S. Offeddu, J. C. Serrano, S. W. Chen, S. E. Shelton, Y. Shin, M. Floryan, R. D. Kamm, J. Biomech. 2021, 119, 110330. 33631662 PMC8314430
- [52]A. C. Newman, M. N. Nakatsu, W. Chou, P. D. Gershon, C. C. W. Hughes, Mol. Biol. Cell 2011, 22, 3791. 21865599 PMC3192859
- [53]M. Murakami, M. Simons, Curr. Opin. Hematol. 2008, 15, 215. 18391788 PMC2745288
- [54]P. Nowak‐Sliwinska, K. Alitalo, E. Allen, A. Anisimov, A. C. Aplin, R. Auerbach, H. G. Augustin, D. O. Bates, J. R. Van Beijnum, R. H. F. Bender, G. Bergers, A. Bikfalvi, J. Bischoff, B. C. Böck, P. C. Brooks, F. Bussolino, B. Cakir, P. Carmeliet, D. Castranova, A. M. Cimpean, O. Cleaver, G. Coukos, G. E. Davis, M. De Palma, A. Dimberg, R. P. M. Dings, V. Djonov, A. C. Dudley, N. P. Dufton, S.‐M. Fendt, et al., Angiogenesis 2018, 21, 425.29766399
- [55]Y.‐S. Torisawa, B. Mosadegh, G. D. Luker, M. Morell, K. S. O'shea, S. Takayama, Integr. Biol. 2009, 1, 649. PMC2825702 20027373
- [56]M. Krieg, Y. Arboleda‐Estudillo, P.‐H. Puech, J. Käfer, F. Graner, D. J. Müller, C.‐P. Heisenberg, Nat. Cell Biol. 2008, 10, 429. 18364700
- [57]R. A. Foty, M. S. Steinberg, Dev. Biol. 2005, 278, 255. 15649477
- [58]N. Sivakumar, H. V. Warner, S. M. Peirce, M. J. Lazzara, bioRxiv 2021, 10.1101/2021.08.05.455232. · DOI
- [59]F. Van Roy, G. Berx, Cell. Mol. Life Sci. 2008, 65, 3756. 18726070 PMC11131785
- [60]P. Murray, G. Frampton, P. Nelson, BMJ 1999, 319, 332. 10435939 PMC1126974
- [61]A. Labernadie, T. Kato, A. Brugués, X. Serra‐Picamal, S. Derzsi, E. Arwert, A. Weston, V. González‐Tarragó, A. Elosegui‐Artola, L. Albertazzi, J. Alcaraz, P. Roca‐Cusachs, E. Sahai, X. Trepat, Nat. Cell Biol. 2017, 19, 224. 28218910 PMC5831988
- [62]M. Janiszewska, M. C. Primi, T. Izard, J. Biol. Chem. 2020, 295, 2495. 31937589 PMC7039572
- [63]P. Salmenperä, E. Kankuri, J. Bizik, V. Sirén, I. Virtanen, S. Takahashi, M. Leiss, R. Fässler, A. Vaheri, Exp. Cell Res. 2008, 314, 3444. 18824166
- [64]B. M. Gumbiner, Nat. Rev. Mol. Cell Biol. 2005, 6, 622. 16025097
- [65]T. J. C. Harris, U. Tepass, Nat. Rev. Mol. Cell Biol. 2010, 11, 502. 20571587
- [66]E. Sahai, I. Astsaturov, E. Cukierman, D. G. Denardo, M. Egeblad, R. M. Evans, D. Fearon, F. R. Greten, S. R. Hingorani, T. Hunter, R. O. Hynes, R. K. Jain, T. Janowitz, C. Jorgensen, A. C. Kimmelman, M. G. Kolonin, R. G. Maki, R. S. Powers, E. Puré, D. C. Ramirez, R. Scherz‐Shouval, M. H. Sherman, S. Stewart, T. D. Tlsty, D. A. Tuveson, F. M. Watt, V. Weaver, A. T. Weeraratna, Z. Werb, Nat. Rev. Cancer 2020, 20, 174. 31980749 PMC7046529
- [67]P. J. Kowalski, M. A. Rubin, C. G. Kleer, Breast Cancer Res. 2003, 5, R217. 14580257 PMC314411
- [68]A. Kumar, A. T. Khani, A. S. Ortiz, S. Swaminathan, Front. Immunol. 2022, 13, 901277. 35865534 PMC9294178
- [69]N. Frey, D. Porter, Biol. Blood Marrow Transplant. 2019, 25, e123. 30586620
- [70]R. M. Sterner, R. Sakemura, M. J. Cox, N. Yang, R. H. Khadka, C. L. Forsman, M. J. Hansen, F. Jin, K. Ayasoufi, M. Hefazi, K. J. Schick, D. K. Walters, O. Ahmed, D. Chappell, T. Sahmoud, C. Durrant, W. K. Nevala, M. M. Patnaik, L. R. Pease, K. E. Hedin, N. E. Kay, A. J. Johnson, S. S. Kenderian, Blood 2019, 133, 697. 30463995 PMC6376281
- [71]L. Xue, Y. Yi, Q. Xu, L. Wang, X. Yang, Y. Zhang, X. Hua, X. Chai, J. Yang, Y. Chen, G. Tao, B. Hu, X. Wang, Cell Discov. 2021, 7, 84. 34518515 PMC8437938
- [72]L. Kang, X. Tang, J. Zhang, M. Li, N. Xu, W. Qi, J. Tan, X. Lou, Z. Yu, J. Sun, Z. Wang, H. Dai, J. Chen, G. Lin, D. Wu, L. Yu, Exp. Hematol. Oncol. 2020, 9, 11. 32523801 PMC7278071
- [73]S. R. Bailey, S. Vatsa, R. C. Larson, A. A. Bouffard, I. Scarfò, M. C. Kann, T. R. Berger, M. B. Leick, M. Wehrli, A. Schmidts, H. Silva, K. A. Lindell, A. Demato, K. M. E. Gallagher, M. J. Frigault, M. V. Maus, Blood Cancer Discovery 2022, 3, 136. 35015685 PMC9414118
- [74]J. Wei, Y. Liu, C. Wang, Y. Zhang, C. Tong, G. Dai, W. Wang, J. E. J. Rasko, J. J. Melenhorst, W. Qian, A. Liang, W. Han, Signal Transduction Targeted Ther. 2020, 5, 134. PMC7388484 32728035
- [75]Z. Wan, A. X. Zhong, S. Zhang, G. Pavlou, M. F. Coughlin, S. E. Shelton, H. T. Nguyen, J. H. Lorch, D. A. Barbie, R. D. Kamm, Small Methods 2022, 6, e2200143. 35373502 PMC9844969
- [76]E. A. Margolis, D. S. Cleveland, Y. P. Kong, J. A. Beamish, W. Y. Wang, B. M. Baker, A. J. Putnam, Lab Chip 2021, 21, 1150. 33538719 PMC7990720
- [77]N. Kosyakova, D. D. Kao, M. Figetakis, F. López‐Giráldez, S. Spindler, M. Graham, K. J. James, J. Won Shin, X. Liu, G. T. Tietjen, J. S. Pober, W. G. Chang, npj Regener. Med. 2020, 5, 1. PMC6944695 31934351
- [78]M. L. Moya, Y.‐H. Hsu, A. P. Lee, C. C. W. Hughes, S. C. George, Tissue Eng., Part C 2013, 19, 730. PMC3719485 23320912
- [79]X. Wang, D. T. T. Phan, A. Sobrino, S. C. George, C. C. W. Hughes, A. P. Lee, Lab Chip 2016, 16, 282. 26616908 PMC4869859
- [80]S. Bang, S.‐R. Lee, J. Ko, K. Son, D. Tahk, J. Ahn, C. Im, N. L. Jeon, Sci. Rep. 2017, 7, 8083. 28808270 PMC5556097
- [81]S. Zhang, Z. Wan, G. Pavlou, A. X. Zhong, L. Xu, R. D. Kamm, Adv. Funct. Mater. 2022, 32, 2206767. 36569597 PMC9783342
- [82]A. Mykuliak, A. Yrjänäinen, A.‐J. Mäki, A. Gebraad, E. Lampela, M. Kääriäinen, T.‐K. Pakarinen, P. Kallio, S. Miettinen, H. Vuorenpää, Front. Bioeng. Biotechnol. 2022, 10, 764237. 35211462 PMC8861308
- [83]S. Kim, H. Lee, M. Chung, N. L. Jeon, Lab Chip 2013, 13, 1489. 23440068
- [84]K. Sugihara, Y. Yamaguchi, S. Usui, Y. Nashimoto, S. Hanada, E. Kiyokawa, A. Uemura, R. Yokokawa, K. Nishiyama, T. Miura, PLoS One 2020, 15, e0240552. 33112918 PMC7592787
- [85]Y. K. Park, T.‐Y. Tu, S. H. Lim, I. J. M. Clement, S. Y. Yang, R. D. Kamm, Cell Mol. Bioeng. 2014, 7, 15. 24660039 PMC3960002
- [86]M. P. Cuchiara, D. J. Gould, M. K. Mchale, M. E. Dickinson, J. L. West, Adv. Funct. Mater. 2012, 22, 4511. 23536744 PMC3607213
- [87]A. Brown, H. He, E. Trumper, J. Valdez, P. Hammond, L. G. Griffith, Biomaterials 2020, 243, 119921. 32172030 PMC7203641
- [88]Z. Wan, S. Zhang, A. X. Zhong, S. E. Shelton, M. Campisi, S. K. Sundararaman, G. S. Offeddu, E. Ko, L. Ibrahim, M. F. Coughlin, T. Liu, J. Bai, D. A. Barbie, R. D. Kamm, Biomaterials 2021, 276, 121032. 34303155 PMC9891349
- [89]G. E. Davis, D. R. Senger, Circ. Res. 2005, 97, 1093. 16306453
- [90]G. C. Sephel, J. M. Davidson, J. Invest. Dermatol. 1986, 86, 279. 3745952
Cited by
Sorted by citations
Cancer-on-chip models for metastasis: importance of the tumor microenvironment
Jouybar, M., de Winde, C. M., Wolf, K., Friedl, P., Mebius, R. E., & den Toonder, J. M. J. (2024) · Trends in Biotechnology · doi:10.1016/j.tibtech.2023.10.001 · Cited by 66 · see citing works
Bridging the gap between tumor-on-chip and clinics: a systematic review of 15 years of studies
Bouquerel, C., Dubrova, A., Hofer, I., Phan, D. T. T., Bernheim, M., Ladaigue, S., Cavaniol, C., Maddalo, D., Cabel, L., Mechta-Grigoriou, F., et al. (2023) · Lab on a Chip · doi:10.1039/d3lc00531c · Cited by 58 · see citing works
Recent advances in vascularized tumor-on-a-chip
Huang, C. B. X., & Tu, T.-Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1150332 · Cited by 34 · see citing works
Microphysiological systems as models for immunologically ‘cold’ tumors
Gaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1389012 · Cited by 12 · see citing works
- Authors
- Wan, Z., Floryan, M. A., Coughlin, M. F., Zhang, S., Zhong, A. X., Shelton, S. E., Wang, X., Xu, C., Barbie, D. A., & Kamm, R. D.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Massachusetts Institute of Technology (US)
- Southern Medical University (CN)
- Corresponding author
- Xu, Chenguang
- Barbie, David A.
- Kamm, Roger D.
- ORCID
- Venue
- Advanced Healthcare Materials
- Publisher
- Wiley
- Published
- 2022-11-15
- Volume
- 12
- Issue
- 14
- Pages
- e2201784-e2201784
- ISSN
- 2192-2640 (ISSN-L)
- 2192-2659
- PMC
- PMC10156888
- OpenAlex
- W4308220489
- Cited by
- 84
- References
- 15
- Citations by year
- 2026: 20 · 2025: 23 · 2024: 32 · 2023: 8 · 2022: 1
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Advanced Healthcare Materials (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Funders
- National Natural Science Foundation of China (81903158, 32170940)
- Natural Science Foundation of Guangdong Province (2022A1515012658)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumor spheroids, tumor vascularization, fibroblast density, immunotherapy evaluation, kidney cancer, lung cancer, ovarian cancer, tumor microenvironment
- MeSH terms
- Humans, Neovascularization, Pathologic, Spheroids, Cellular, Microfluidics, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review